Literature DB >> 11596920

Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.

R Tonhosolo1, G Wunderlich, M U Ferreira.   

Abstract

The merozoite surface protein-2 (MSP-2) is a major vaccine candidate for the asexual blood stage of Plasmodium falciparum. MSP-2 is essentially dimorphic, and allelic families are named after the representative isolates FC27 and IC1. The polymorphic central region contains immunodominant repeats, which vary in number, length, and sequence within and between allelic families. We have examined the antibody recognition of repeat regions from both MSP-2 allelic families expressed as recombinant fusion peptides. The results are summarized as follows. (1) Immunization of mice with the fusion peptides elicited IgG antibodies that cross-reacted with the native MSP-2 molecule in an allelic family-specific manner. (2) These mouse antibodies recognized the recombinant proteins in both a variant-specific and a family-specific manner, as shown in inhibition immunoassays. Antibodies raised against the peptide FC27 seemed to be essentially variant-specific, since the soluble form of the S20 antigen (a member of FC27 family) had relatively little inhibitory effect on them. (3) The overall pattern of human IgG antibody responses to MSP-2 in Karitiana Indians, a population continuously exposed to hypoendemic malaria in the Brazilian Amazon Region, differs from that described in hyperendemic areas in Africa and Papua New Guinea in two important features: there was no clear age-dependent increase in the prevalence and mean concentration of specific IgG antibodies, and there was no skewing towards the IgG3 subclass in antibody responses. (4) The relatively poor correlation between concentrations of IgG antibodies that are specific for members of the same allelic family suggests that recognition of MSP-2 peptides by naturally acquired antibodies was largely variant-specific in this population. The potential role of naturally acquired variant-specific antibodies in immune evasion, by selecting mutant parasites carrying insertions or deletions of repeat sequences, is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596920     DOI: 10.1111/j.1550-7408.2001.tb00191.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  9 in total

1.  Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil.

Authors:  Kelly A Kanunfre; Fabiana M S Leoratti; Erika H E Hoffmann; Rui R Durlacher; Antônio W Ferreira; Sandra L Moraes-Avila; Marcelo U Ferreira
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 2.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

3.  Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.

Authors:  Kézia K G Scopel; Cor J F Fontes; Marcelo U Ferreira; Erika M Braga
Journal:  Clin Vaccine Immunol       Date:  2006-07

4.  Genetic diversity of the malaria vaccine candidate merozoite surface protein 1 gene of Plasmodium vivax field isolates in Republic of Korea.

Authors:  Eun-Taek Han; Yue Wang; Chae Seung Lim; Jun Hwi Cho; Jong-Yil Chai
Journal:  Parasitol Res       Date:  2011-05-10       Impact factor: 2.289

5.  Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria.

Authors:  Hodan Ahmed Ismail; Ulf Ribacke; Linda Reiling; Johan Normark; Tom Egwang; Fred Kironde; James G Beeson; Mats Wahlgren; Kristina E M Persson
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

6.  Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians.

Authors:  Melissa S Bastos; Mônica da Silva-Nunes; Rosely S Malafronte; Erika Hellena E Hoffmann; Gerhard Wunderlich; Sandra L Moraes; Marcelo U Ferreira
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

7.  Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins.

Authors:  Jon Eric Tongren; Patrick H Corran; William Jarra; Jean Langhorne; Eleanor M Riley
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.

Authors:  Nuno Sepúlveda; Cristiane Guimarães Morais; Luiza Carvalho Mourão; Matheus França Freire; Cor Jesus F Fontes; Marcus Vinícius G Lacerda; Chris J Drakeley; Érika Martins Braga
Journal:  Malar J       Date:  2016-11-16       Impact factor: 2.979

9.  Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.

Authors:  Márcia M Medeiros; Wesley L Fotoran; Rosimeire C dalla Martha; Tony H Katsuragawa; Luiz Hildebrando Pereira da Silva; Gerhard Wunderlich
Journal:  BMC Infect Dis       Date:  2013-12-28       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.